BERLINBERLIN — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, reported that its earnings in the third quarter were close to half what they were a year earlier, but the ...

Good morning and afternoon. Thank you for joining us today for BioNTech’s fourth quarter and full year 2022 earnings call. As a brief reminder, the slides that accompany this call, and the fourth ...

Moderna filed lawsuits against Pfizer and BioNTech, the company said Friday, alleging they copied Moderna’s “foundational” mRNA technology used for its Covid-19 vaccine to create their own coronavirus ...

Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech “for infringing patents central to (its) mRNA technology platform,” the company said in a news release Friday. “Moderna ...

MAINZ, Germany, October 26, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for ...

The biotech is still heavily associated with COVID-19, due to the Comirnaty vaccine it co-developed with Pfizer. However, with the declines in hospitalizations and deaths in many parts of the world, ...

Pfizer-BioNTech’s Covid-19 vaccine is effective in preventing illness from Covid-19 in nearly three in four young children and it provides protection across Covid-19 variants, according to a new ...

COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday ...

Moderna alleges Pfizer and its German partner BioNTech copied technology that was developed years before the pandemic. Early in the pandemic, Moderna said it would not enforce its Covid-19 patents. In ...

Moderna is suing Pfizer and BioNTech, claiming that the companies’ COVID-19 vaccine infringes on Moderna’s patents. The COVID-19 vaccines from Moderna and Pfizer-BioNTech both use messenger RNA (mRNA) ...